SAFE-T-SYRINGE
DEAD

Serial Number

85530271

Owner

Asepsis Pharmaceuticals Inc.

First Use Date

Jan 31, 2012

Filing Date

Jan 31, 2012

Add to watchlist:

No watchlists yet
View on USPTO

SAFE-T-SYRINGE Trademark

Serial Number: 85530271 • Registration: 4519370

SAFE-T-SYRINGE is a trademark filed by Asepsis Pharmaceuticals Inc. on January 31, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Asepsis Pharmaceuticals Inc. (11 trademarks)

183 Providence New London Turnpike
North Stonington, CT 06359

Entity Type: 03

Trademark Details

Filing Date

January 31, 2012

Registration Date

April 22, 2014

First Use Anywhere

January 31, 2012

First Use in Commerce

January 31, 2012

Cancellation Date

November 1, 2024

Goods & Services

Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Nov 1, 2024 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 22, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Aug 29, 2019 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Aug 29, 2019 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 29, 2019 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2019 TCCA
TEAS SECTION 8 RECEIVED
Aug 12, 2019 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 22, 2019 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2018 TCCA
REGISTERED-SUPPLEMENTAL REGISTER
Apr 22, 2014 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 15, 2014 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Mar 6, 2014 CNTA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 6, 2014 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 5, 2013 RCSC
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Feb 26, 2013 AAUA
CORRESPONDENCE E-MAILED
Feb 24, 2013 GRML
SUSPENSION LETTER WRITTEN
Feb 24, 2013 CNSL
USE AMENDMENT ACCEPTED
Feb 24, 2013 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2013 TEME
AMENDMENT TO USE PROCESSING COMPLETE
Feb 24, 2013 AUPC
USE AMENDMENT FILED
Feb 24, 2013 IUAF
ASSIGNED TO LIE
Feb 24, 2013 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2013 TROA
TEAS AMENDMENT OF USE RECEIVED
Feb 22, 2013 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2013 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2013 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2013 CNRT
NOTICE OF REVIVAL - E-MAILED
Nov 21, 2012 NREV
PETITION TO REVIVE-GRANTED
Nov 21, 2012 PETG
TEAS PETITION TO REVIVE RECEIVED
Nov 21, 2012 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 22, 2012 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 22, 2012 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 26, 2012 GNRN
NON-FINAL ACTION E-MAILED
Mar 26, 2012 GNRT
NON-FINAL ACTION WRITTEN
Mar 26, 2012 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2012 DOCK
NOTICE OF PSEUDO MARK MAILED
Feb 7, 2012 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2012 NWOS
NEW APPLICATION ENTERED
Feb 3, 2012 NWAP